← Leaderboards
Andrew Hayhurst
Texas Biomedical Research Institute
$5,397,791
Attributed
$5,397,791
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $544.5K · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,397,791 · 7
By mechanism
R21$3,037,664 · 6
R01$2,360,127 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesProteinsDiagnosticReagentBaseEpitopesVirusEbola VirusEngineeringFutureDetectionLlamaDesignAffinityNucleoproteinsBindingEnzymesPeptidesNucleic AcidsCross ReactivityParticleFilovirusEnsureMutant
Grant awards (17)
Novel antiviral strategy offering forward capability and reduced risk of escape$247,500
R21 · FY2024 · AI · contact PI
Novel antiviral strategy offering forward capability and reduced risk of escape$297,000
R21 · FY2023 · AI · contact PI
Nanobody toolkit for human coronavirus classification$247,500
R21 · FY2022 · AI · contact PI
Nanobody toolkit for human coronavirus classification$297,000
R21 · FY2021 · AI · contact PI
Engineering pathogen triggered biomineralization to enable a new generation of point-of-care tests$247,500
R21 · FY2021 · AI · contact PI
Engineering pathogen triggered biomineralization to enable a new generation of point-of-care tests$297,000
R21 · FY2020 · AI · contact PI
Mechanism and Evolution of Filoviral Monoclonal Affinity Reagent Sandwich Assays$470,814
R01 · FY2019 · AI · contact PI
Mechanism and Evolution of Filoviral Monoclonal Affinity Reagent Sandwich Assays$470,814
R01 · FY2018 · AI · contact PI
Mechanism and Evolution of Filoviral Monoclonal Affinity Reagent Sandwich Assays$470,814
R01 · FY2017 · AI · contact PI
Mechanism and Evolution of Filoviral Monoclonal Affinity Reagent Sandwich Assays$476,871
R01 · FY2016 · AI · contact PI
Mechanism and Evolution of Filoviral Monoclonal Affinity Reagent Sandwich Assays$470,814
R01 · FY2015 · AI · contact PI
Improved Tumor Targeting of Salmonella VNP20009 via Ice-llama Antibody Guidance$231,651
R21 · FY2014 · CA · contact PI
Rapid Ligand Pairing Strategy to Simplify Diagnostic Immunoassay Assembly$228,750
R21 · FY2014 · AI · contact PI
Rapid Ligand Pairing Strategy to Simplify Diagnostic Immunoassay Assembly$274,500
R21 · FY2013 · AI · contact PI
Improved Tumor Targeting of Salmonella VNP20009 via Ice-llama Antibody Guidance$199,013
R21 · FY2013 · CA · contact PI
Heat Stable Filoviral Diagnostics$213,750
R21 · FY2009 · AI · contact PI
Heat Stable Filoviral Diagnostics$256,500
R21 · FY2008 · AI · contact PI